APTT에서 경계치에 속한 정상 성인의 혈액응고인자 활성도 분석
Analysis of Coagulation Factor Activity of Normal Adults with APTT Limit Range
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The coagulation factor activity compared two groups of the lower 10% (29.1∼30.9 sec) and the upper 10% (38.0∼41.9 sec) of the normal reference range of aPTT. The aim of this study was to investigate the influence of sex, age, and ABO blood type on coagulation factor activity. There was significant difference in the activity of the coagulation factor assay based on age. The VIII (p＜0.0001) and IX (p=0.0050) in the lower group of samples from those over sixty years of age is higher than from those under sixty. In contrast, XII (p=0.0285) for samples over sixty was lower than for samples under sixty. While in the upper group V (p=0.0219), VIII (p=0.0005), and IX (p=0.0014) for samples from the over sixty group was higher than those under sixty. In the case of activity of coagulation factor between O and non-O blood type, VIII (p＜0.001) activity of the non-O blood type was higher than that of the O blood type in the both groups. The XII (p=0.016) activity of non-O blood type was lower than that of O blood type in the upper group. According to the multiple logistic regression analysis, when other variables are under the same conditions between lower and upper groups, there is a strong possibility for the lower group when activity of V (p=0.001), VIII (p＜0.001), X (p＜0.001) and XII (p＜0.001) is increased. Furthermore, there is also a strong possibility of upper group when activity of II (p=0.004) and IX (p=0.012) is increased. However, no significant difference in between sex, age and XI was observed.
Abstract
The coagulation factor activity compared two groups of the lower 10% (29.1∼30.9 sec) and the upper 10% (38.0∼41.9 sec) of the normal reference range of aPTT. The aim of this study was to investigate the influence of sex, age, and ABO blood type on coagulation factor activity. There was significant difference in the activity of the coagulation factor assay based on age. The VIII (p＜0.0001) and IX (p=0.0050) in the lower group of samples from those over sixty years of age is higher than from those under sixty. In contrast, XII (p=0.0285) for samples over sixty was lower than for samples under sixty. While in the upper group V (p=0.0219), VIII (p=0.0005), and IX (p=0.0014) for samples from the over sixty group was higher than those under sixty. In the case of activity of coagulation factor between O and non-O blood type, VIII (p＜0.001) activity of the non-O blood type was higher than that of the O blood type in the both groups. The XII (p=0.016) activity of non-O blood type was lower than that of O blood type in the upper group. According to the multiple logistic regression analysis, when other variables are under the same conditions between lower and upper groups, there is a strong possibility for the lower group when activity of V (p=0.001), VIII (p＜0.001), X (p＜0.001) and XII (p＜0.001) is increased. Furthermore, there is also a strong possibility of upper group when activity of II (p=0.004) and IX (p=0.012) is increased. However, no significant difference in between sex, age and XI was observed.
참고문헌 (25)
- CLSI, "Defining, establishing and verifying reference intervals in the clinical laboratory; approved guideline" (2008), Clinical and Laboratory Standards Institute
- Favaloro EJ, "Cross-laboratory audit of normal reference ranges and assessment of ABO blood group, gender and age on detected levels of plasma coagulation factors", Blood Coagul Fibrinolysis, 16, pp.597~605 (2005)
- Folsom AR, "Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC)Study Investigators", Ann Epidemiol, 2, pp.481~494 (1992)
- Fourel V, "Influence of age, sex and ABO blood group on activated partial thromboplastin time", Haemostasis, 23, pp.321~326 (1993)
- Gausman JN, "Unaccuracy of a "spiked curve" for monitoring UFH therapy", Am J Clin Pathol, 135, pp.870~876 (2011)
- Gill JC, "The effect of ABO blood group on the diagnosis of von Willebrand disease", Blood, 69, pp.1691~1695 (1987)
- Jang JH, "Establishment of reference intervals for von Willebrand factor antigen and eight coagulation factors in a Korean population following the Clinical and Laboratory Standards Institute guidelines", Blood Coagul Fibrinolysis, 21, pp.251~255 (2010)
- Jeremic M, "Factor VIII(AHG) levels in 1016 regular blood donors: The effects of age, sex, and ABO blood groups", Scand J Clin Lab Invest, 36, pp.461~466 (1976)
- Kim MJ, "Influence of Age, Sex and ABO Blood Group on Activated Partial Thromboplastin Time (APTT)", Korean J Hemosat Thromb, 2, pp.155~159 (1995)
- Kitchen S, "Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage", J Clin Pathol, 49, pp.10~14 (1996)
- 구본경, "헤파린민감도평가를 위한 두 가지 방법의 비교; 체외에서 헤파린 혼합 혈장을 사용한 aPTT 검사와 헤파린 치료중인 환자 혈장을 사용한 anti-Xa 검사", 대한임상검사과학회지, 43(4), pp.133~137 (2011), 대한임상검사과학회
- Langdell RD, "Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure", J Lab Clin Med, 41, pp.637~647 (1953)
- Lowe GD, "Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use", Br J Haematol, 97, pp.775~784 (1997)
- Mari D, "Hemostasis factors and aging", Exp Gerontol, 43, pp.66~73 (2008)
- McCallum CJ, "Factor VIII levels and blood group antigens", Thromb Haemost, 50, pp.757~ (1983)
- McLellan DS, "The relationship between coagulation factor VIII and ABO blood group status", Med Lab Sci, 45, pp.131~134 (1988)
- Moellera A, "Influence of ABO blood groups on primary hemostasis", Transfusion, 41, pp.56~60 (2001)
- O'Donnell JS, "Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis", Blood, 106, pp.1988~1991 (2005)
- Orstavik KH, "Factor VIII and Factor in a twin population: Evidence for a major effect of ABO locus on factor VIII level", Am J Hum Genet, 37, pp.89~101 (1985)
- Preston AE, "The plasma concentration of factor VIII in the normal population. II. The effects of age, sex and blood group", Br J Haematol, 10, pp.238~245 (1964)
- Proctor RR, "The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies", Am J Clin Pathol, 36, pp.212~219 (1961)
- Ross JW, "Analytic clinical laboratory precision:state of the art for thirty-one analysis", Am J Clin Pathol, 74, pp.521~530 (1980)
- Shetty S, "Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer", Blood Coagul Fibrinolysis, 14, pp.493~497 (2003)
- Souto JC, "Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time", Arterioscler Thromb Vasc Biol, 20, pp.2024~2028 (2000)
- Sukhu K, "Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease", Clin Lab Haematol, 25, pp.247~249 (2003)